Jointown Pharmaceutical Group Company Limited’s Net Profit Dropped 39.5% in First Quarter of 2022

Jointown Pharmaceutical Group Company Limited (九州通医药集团股份有限公司) (600998.SH) reported a net profit of 478.2 million yuan in the first quarter of 2022, down 39.5% year-on-year.

Meanwhile, the company posted 35.2 billion yuan in revenue, up 7.7% year-on-year.

At the end of the reporting period, it had 88.7 billion yuan in total assets and 61.1 billion yuan in total liabilities, with a liability-to-asset ratio of 68.9%.